MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹616 Cr | ₹804 Cr | ₹276 Cr | ₹294 Cr | ₹209 Cr |
What is the latest Short Term Loans and Advances ratio of MANKIND PHARMA ?
Year | Short Term Loans and Advances |
---|---|
Mar2023 | ₹616 Cr |
Mar2022 | ₹804 Cr |
Mar2021 | ₹276 Cr |
Mar2020 | ₹294 Cr |
Mar2019 | ₹209 Cr |
How is Short Term Loans and Advances of MANKIND PHARMA Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2023 | ₹616 Cr | -23.44 | |
Mar2022 | ₹804 Cr | 191.64 | |
Mar2021 | ₹276 Cr | -6.26 | |
Mar2020 | ₹294 Cr | 40.65 | |
Mar2019 | ₹209 Cr | - |
Compare Short Term Loans and Advances of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹83,865.6 Cr | -4% | -8.3% | 51.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,470.0 Cr | 0.4% | -0.4% | 61.2% | Stock Analytics | |
CIPLA | ₹112,990.0 Cr | -1.1% | 1.7% | 53.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,846.0 Cr | 5.9% | 11.3% | 94.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,849.0 Cr | -0.1% | 3.9% | 20% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,742.1 Cr | -2% | -4.2% | 29.3% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -4% |
-8.3% |
51.1% |
SENSEX | 1.7% |
0.7% |
19.2% |
You may also like the below Video Courses